Drug Research
To Curb Medicine Inequality, 3-Year Novel Strategy Announced
A novel strategy for 2023–25 adopted by the Medicines Patent Pool looks to lessen the inequalities in access by way of enhancing the affordability as...
Drug Research
EC approves Regeneron-Sanofi’s Dupixent for eosinophilic esophagitis
The European Commission (EC) has granted marketing authorisation for Regeneron Pharmaceuticals and Sanofi’s Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE).
Dupixent’s expanded authorisation in the European...
Drug Research
Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater...
Seqens Group opens the Seqens Boston R&D Center, a state-of-the-art, 15,000 square-foot R&D center in Devens, Mass. that serves as one of the company’s global...
Drug Research
Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced mRNA-1345, an investigational mRNA vaccine candidate for respiratory syncytial virus (RSV), has been...
Drug Research
Lilly Plans to Invest Additional $450 million at Manufacturing...
Eli Lilly and Company announced plans to invest an additional $450 million and create at least 100 new jobs to expand its manufacturing capacity at...
Drug Research
SK bioscience introduces new partnership model to establish regional...
SK bioscience, a global innovative vaccine and biotech company, introduced a new global partnership model under the title of ‘Preparing for Next Pandemic through Global...
Drug Research
Catalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility in Gosselies,...
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, announced the opening of a new commercial-scale plasmid DNA (pDNA)...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.